Validation of the Peak Pruritus‐Numerical Rating Scale in patients with chronic plaque psoriasis: results from a phase 2 study

Documenti analoghi

• Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting
  di: Esteban Daudén, et al.
  Pubblicazione: (2024)
• Efficacy, Tolerance, and Safety of a Novel Botanical Anti‐Inflammatory Moisturizer in Rosacea: Results From a Double‐Blinded, Randomized Controlled Trial
  di: Zoe Diana Draelos
  Pubblicazione: (2026)
• Pruritus of Unknown Origin Treated With Aripiprazole
  di: Mariana Chrispim Gimenez, et al.
  Pubblicazione: (2026)
• A large exophytic plaque on the shoulder of a skin of color patient
  di: Kirk Williams, et al.
  Pubblicazione: (2024)
• Tapinarof cream for the treatment of plaque psoriasis: Efficacy and safety results from 2 Japanese phase 3 trials
  di: Atsuyuki Igarashi, et al.
  Pubblicazione: (2024)